Chronic bronchitis
Chronic bronchitis is a chronic nonspecific inflammation of the trachea, bronchial mucosa and surrounding tissues. Clinically, the main symptoms are repeated attacks of cough, sputum or wheezing, which last for 3 months each year for more than 2 consecutive years. The early symptoms are mild, often occurring in winter and relieved in spring and summer. In the late stage, due to the aggravation of inflammation, the symptoms may exist all year round. Its pathological characteristics are bronchial gland hyperplasia and increased mucosal secretion. The disease progresses slowly and progressively, often complicated by obstructive emphysema. In severe cases, pulmonary hypertension and even cor pulmonale often occur.
Related Drugs
Carbocisteine Tablets
Indication: Used for children's cough and breathing difficulties caused by thick sputum.
Manufacturer:
Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.
Carbocisteine Tablets
Indication: Used for children's cough and breathing difficulties caused by thick sputum.
Manufacturer:
Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.
Children's compound sulfamethoxazole tablets
Indication: In recent years, many common clinical pathogens often show resistance to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, patients with a history of at least one attack of Pneumocystis carinii disease or HIV-infected adults can use it, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count. 7. Traveler's diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Manufacturer:
Harbin Pharmaceutical Group Pharmaceutical Factory No.6
Carbocisteine Tablets
Indication: Used for children's cough and breathing difficulties caused by thick sputum.
Manufacturer:
Yunpeng Pharmaceutical Group Co., Ltd.
UNIPHYL- theophylline anhydrous_tablet
Indication: Theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.
Manufacturer:
Purdue Pharmaceutical Products LP